Michael Gross

Managing Director


Joined: 2008

Office Phone:

(248) 489-9000

Get Started

    and access,

  •     37K PE/M&A Contacts
  •     +
  •     3.8K PE Firms
  •     3.0K M&A Advisors
  •     133K Transactions
  •     142K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities


Michael is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. Michael serves as a board director for Beringea portfolio companies MI Bioresearch, D3O, Delphinus Medical Technologies, InTouch Health, Intervention Insights, Xanitos, Freeosk, Rethink and Fiber By-Products. Previous portfolio companies include Pioneer Surgical Technologies (acquired by RTI Biologics), Relume Technologies (acquired by Revolution Lighting), and EcoSynthetix (offered publicly at TSX: ECO). Prior to joining Beringea, Michael was a vice president of investment banking with P&M Corporate Finance (PMCF). While at PMCF, Michael led M&A transactions and capital raises for companies in the life sciences, health care and outsourced business services sectors. Before working at PMCF, Michael worked in the investment banking group at Stout Risius Ross, Inc. Michael is a CFA charterholder and earned a B.A. in Finance from Michigan State University.


Michigan State University , Michigan,
1 of 118

Board Member

Intervention Insights, Inc.

Molecular Imaging, Inc.

Xanitos, Inc.

Freeosk, Inc.

Delphinus Medical Technologies LLC

InTouch Health, Inc.